Cipher Pharmaceuticals Inc Sustainability Reports

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company with a robust portfolio of commercial stage products, primarily focusing on dermatology. The company acquires, in-licenses, and commercializes prescription products while utilizing operational partnerships to manage a lean corporate structure.

Sector: Manufacturing

Country: Canada

Exchange: Toronto Stock Exchange

LEI: 213800T44AN9XSAOY605

FIGI: BBG001SBWXS4

9 reports from 2016 to 2025

• Cipher Pharmaceuticals Inc 2025 Consolidated Financial Statements
• Cipher Pharmaceuticals Inc 2024 Modern Slavery Report
• Cipher Pharmaceuticals Inc 2022 Consolidated Financial Statements
• Cipher Pharmaceuticals Inc 2021 Consolidated Financial Statements
• Cipher Pharmaceuticals Inc 2020 Annual Report